IgM-associated gut bacteria in obesity and type 2 diabetes in C57BL/6 mice and humans

Pearson, James A. ORCID: https://orcid.org/0000-0002-2867-2269, Ding, Heyuan, Hu, Changyun, Peng, Jian, Galuppo, Brittany, Wong, F. Susan ORCID: https://orcid.org/0000-0002-2812-8845, Caprio, Sonia, Santoro, Nicola and Wen, Li 2022. IgM-associated gut bacteria in obesity and type 2 diabetes in C57BL/6 mice and humans. Diabetologia 65 (8) , pp. 1398-1411. 10.1007/s00125-022-05711-8

	PDF - Supplemental Material Download (421kB)
	PDF - Published Version Download (1MB)

Abstract

Abstract: Aims/hypothesis: IgM is the primary antibody produced by B cells and we hypothesise that IgM antibodies to gut microbiota may play a role in immunometabolism in obesity and type 2 diabetes. To test our hypothesis, we used B6 mice deficient in activation-induced cytidine deaminase (Aid−/− [also known as Aicda−/−]) which secrete only IgM antibodies, and human faecal samples. Methods: We studied the immunometabolic effects and gut microbial changes in high-fat-diet-induced obesity (HFDIO) in Aid−/− B6 mice compared with wild-type mice. To determine similarities between mice and humans, human stool samples were collected from children and adolescents who were obese with normal glucose tolerance (NGT), obese with glucose intolerance (IGT), or obese and newly diagnosed with type 2 diabetes, for faecal microbiota transplant (FMT) into germ-free (GF) B6 mice and we assessed IgM-bound bacteria and immune responses. Results: Compared with wild-type mice, Aid−/− B6 mice developed exacerbated HFDIO due to abundant levels of IgM. FMT from Aid−/− B6 to GF B6 mice promoted greater weight gain in recipient mice compared with FMT using wild-type mouse faecal microbiota. Obese youth with type 2 diabetes had more IgM-bound gut bacteria. Using the stools from the obese youth with type 2 diabetes for FMT to GF B6 mice, we observed that the gut microbiota promoted body weight gain and impaired glucose tolerance in the recipient GF B6 mice. Importantly, some clinical features of these obese young individuals were mirrored in the GF B6 mice following FMT. Conclusions/interpretation: Our results suggest that IgM-bound gut microbiota may play an important role in the immuno-pathogenesis of obesity and type 2 diabetes, and provide a novel link between IgM in obesity and type 2 diabetes in both mice and humans. Data availability: The 16s rRNA sequencing datasets supporting the current study have been deposited in the NCBI SRA public repository (https://www.ncbi.nlm.nih.gov/sra; accession no. SAMN18796639). Graphical abstract:

Item Type:	Article
Date Type:	Publication
Status:	Published
Schools:	Medicine
Additional Information:	License information from Publisher: LICENSE 1: URL: http://creativecommons.org/licenses/by/4.0/, Type: open-access
Publisher:	Springer
ISSN:	0012-186X
Funders:	MRC
Date of First Compliant Deposit:	15 July 2022
Date of Acceptance:	25 February 2022
Last Modified:	12 Oct 2023 04:03
URI:	https://orca.cardiff.ac.uk/id/eprint/151300

Citation Data

Cited 3 times in Scopus. View in Scopus. Powered By Scopus® Data

Actions (repository staff only)

Edit Item